medvi compounded Tirzepatide

Last updated: June 23, 2026

Quick Answer: MEDVi compounded tirzepatide is a telehealth-based GLP-1 weight-loss program that ships compounded tirzepatide injections and oral tablets directly to your door. Starting at $349 for the first month, it is one of the more affordable alternatives to brand-name Zepbound or Mounjaro. MEDVi holds a 4.4/5 Trustpilot rating from over 4,000 reviews as of mid-2026, though a February 2026 FDA warning letter about marketing claims is worth knowing before you enroll.

---

Our Verdict Box

Our Top GLP-1 Providers

Table of Contents - [Open] ➨

Toggle

7 Best GLP-1 Providers Ranked: Accreditation, Flexibility & Support Compared (2026 Update)

32,000+ Patients Can't All Be Wrong: See the Top-Rated GLP-1 Providers. We compared the leading online GLP-1 providers based on program features, clinical support, convenience, and overall value.

✓ Quick comparison: See which provider best fits your needs.

★ Our Top Pick

1

BMI MD

BMI MD GLP-1 Microdosing Plan

Best for: Microdosing & maintenance

• Specialized microdosing options, including sublingual drops and low-dose injections
• Designed for people interested in maintaining weight or gradually adjusting treatment
• Bundled program structure without a separate monthly platform membership
• Online access makes the process convenient from home

4.9

★★★★★

32,200+ Reviews

Check BMI MD

See current program options

2

DirectMEDs

DirectMeds Weight Loss Solutions

Best for: Straightforward online access

• Online weight-loss program with a straightforward patient experience
• Compounded medication options through state-licensed compounding pharmacies
• Includes clinical consultation as part of the process
• Provides shipping updates to help patients track their orders

4.8

★★★★★

2,100+ Reviews

Explore DirectMEDs

View current program details

3

MEDVi

MEDVi Flat-Rate Telehealth

Best for: Predictable program structure

• Flat-rate telehealth approach designed for easier budgeting
• No dosage-based pricing increases within the advertised program structure
• Offers injectable and oral thin-film delivery options
• Includes medical screening and asynchronous provider consultations

4.6

★★★★☆

1,800+ Reviews

Explore MEDVi

See current treatment options

4

ShedRx GLP-1

Gala GLP-1 Care Program

Best for: Ongoing clinician messaging

• Text-based access to state-licensed clinicians
• Cold-chain medication shipping included in the program
• Month-to-month program structure
• Designed for people who value convenient ongoing support

4.5

★★★★☆

1,400+ Reviews

Start Assessment

See if the program fits

5

Measured

Measured GLP-1 Metabolic Health

Best for: Metabolic health tracking

• Comprehensive metabolic health screening and intake analysis
• Designed around longer-term metabolic health management
• Responsive dashboard with integrated health tracking tools
• Useful option for patients who value a more data-focused experience

4.3

★★★★☆

900+ Reviews

Explore Measured

Review the complete program

6

Gala GLP-1

Refills GLP-1 (TryRefills Plan)

Best for: Side-effect support

• Clinical guidance designed to help patients manage common treatment concerns
• Includes foundational nutritional strategies alongside medication
• Designed around predictable ongoing treatment
• No hidden startup or processing fees according to the program information provided

4.2

★★★★☆

450+ Reviews

Explore Refills

View current program details

7

Refills GLP-1

AltRx GLP-1 Transactional Reorders

Best for: Experienced patients

• Transactional reorder model without recurring auto-billing
• Designed for patients who already understand their treatment routine
• Fast text-to-order process for convenient reorders
• Offers injectable and fast-dissolving tablet variations

4.1

★★★★☆

280+ Reviews

Explore Refills

See current options

Important: GLP-1 medications require medical evaluation and may not be appropriate for everyone. Program availability, eligibility, medication options, and terms can change. Review the provider's current information and consult a qualified healthcare professional before starting treatment.

Overall Rating: 4.4 / 5 — Recommended with Caveats

Best for: Adults with a BMI of 27+ seeking affordable compounded tirzepatide without insurance
Best for: Patients who want fully remote, subscription-based GLP-1 care
Best for: People in 49 states who cannot afford brand-name Zepbound ($1,000+/month)
Skip if: You live in North Dakota, or require in-person care in Kansas, Indiana, Mississippi, New Mexico, Oklahoma, or West Virginia
Skip if: You are pregnant, breastfeeding, or have a personal/family history of medullary thyroid carcinoma

Check the Lowest Price on MEDVi’s Official Site

---

Key Takeaways

• MEDVi compounded tirzepatide injections start at $349 for month one, then approximately $399 per month ongoing [1]
• Oral tirzepatide tablets are available at $279 for month one, but this form has not been evaluated or approved by the FDA for safety or efficacy [1]
• MEDVi received an FDA warning letter in February 2026 for misleading marketing claims — not for pharmacy quality issues [2]
• The platform operates in 49 U.S. states (excluding North Dakota) and uses a cash-pay model; HSA/FSA payments are accepted [2][4]
• Compounded tirzepatide contains the same active ingredient as Mounjaro and Zepbound but is not individually FDA-approved as a finished product [6]
• MEDVi provides free temperature-controlled shipping, regular check-ins, and dose adjustment support [5]
• An active class-action lawsuit (Day v. OpenLoop Health) challenges the oral tablet form’s ability to deliver therapeutic drug levels into the bloodstream [1]
• For cost comparisons with brand-name options, see our tirzepatide cost breakdown for 2026

---

What Is MEDVi Compounded Tirzepatide and How Does It Work?

MEDVi is a telehealth platform that connects patients with licensed providers who can prescribe compounded tirzepatide for weight loss and metabolic health. Compounded tirzepatide contains the same active molecule as the FDA-approved drugs Mounjaro (for type 2 diabetes) and Zepbound (for obesity), but it is prepared by state-licensed compounding pharmacies rather than manufactured by Eli Lilly.

Tirzepatide works by activating two gut hormone receptors simultaneously: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). This dual-action mechanism suppresses appetite, slows gastric emptying, and improves insulin sensitivity. Clinical trials for Zepbound showed average weight loss of up to 20.9% of body weight over 72 weeks at the highest dose, according to the SURMOUNT-1 trial published in the New England Journal of Medicine (2022).

Unlike standard GLP-1 drugs, tirzepatide’s GIP receptor activation appears to add an additional layer of appetite control, which is why many clinicians and patients report stronger results compared to semaglutide-only options. For a deeper look at how these two medications compare, see our guide on the difference between semaglutide and tirzepatide.

MEDVi’s two product formats:

• Weekly subcutaneous injection: The standard delivery method, matching how Mounjaro and Zepbound are administered. Compounded by state-licensed pharmacies.
• Daily oral tablet: A newer and more convenient format. However, the FDA has not evaluated or approved any oral tirzepatide formulation for safety or efficacy. An active class-action lawsuit also questions whether oral tablets can deliver therapeutic drug levels into the bloodstream. [1]

“If you are serious about tirzepatide therapy, the injection form is the evidence-backed choice. The oral tablet is convenient, but its clinical standing is currently unresolved.”

Start Your MEDVi Consultation Today

---

How Much Does MEDVi Compounded Tirzepatide Cost?

MEDVi compounded tirzepatide is priced well below brand-name alternatives, which often exceed $1,000 per month without insurance. Here is the current pricing structure as of 2026:

Format	Month 1 Price	Ongoing Monthly Price
Weekly injection	$349	~$399
Daily oral tablet	$279	Higher than month 1 (exact figure varies)

MEDVi does not accept insurance. Patients pay out of pocket, but HSA and FSA funds are eligible. [4]

For context, brand-name Zepbound lists at over $1,000 per month without insurance, and even discounted options through manufacturer savings programs have income and eligibility restrictions. Compounded tirzepatide through MEDVi can represent savings of 60% or more compared to the brand-name drug.

For a broader look at what compounded GLP-1 medications cost across providers, see our full GLP-1 cost guide.

Choose MEDVi injections if: You want the clinically validated delivery method and can budget roughly $399 per month after the first month.

Choose the oral tablet if: Convenience is your top priority and you understand the current regulatory and legal uncertainty around that format.

Common mistake: Many patients enroll expecting insurance reimbursement. MEDVi is strictly cash-pay, so budget accordingly before starting.

---

Is MEDVi Compounded Tirzepatide Safe and Legal?

Compounded tirzepatide from MEDVi is prepared by state-licensed compounding pharmacies and is legal under FDA compounding regulations, provided the active ingredient is on the FDA’s list of bulk drug substances that can be used in compounding. [6] However, compounded medications are not individually FDA-approved as finished products, which means they do not go through the same pre-market approval process as Mounjaro or Zepbound.

Key safety and legal facts:

• The compounding pharmacies MEDVi uses are state-licensed and operate under applicable pharmacy laws [1]
• In February 2026, the FDA issued a warning letter to MEDVi for false or misleading marketing claims about its compounded semaglutide and tirzepatide products. This was a marketing compliance issue, not a finding about pharmacy product quality [2]
• The oral tirzepatide tablet form is the subject of an active class-action lawsuit (Day v. OpenLoop Health) questioning its bioavailability [1]
• For patients in Kansas, Indiana, Mississippi, New Mexico, Oklahoma, and West Virginia, an in-person visit is required before the first prescription can be issued [2]

For a broader look at the safety and legal landscape of compounded GLP-1 medications, our article on whether compounded semaglutide is safe and legal covers the regulatory framework in detail.

“MEDVi compounded tirzepatide injections are a legal option for most U.S. adults. But the FDA warning letter and the oral tablet lawsuit are real flags that informed patients should weigh carefully before enrolling.”

See If You Qualify for MEDVi Tirzepatide

---

What Do Real Patients Say About MEDVi Compounded Tirzepatide?

As of May 2026, MEDVi holds a 4.4 out of 5 rating on Trustpilot, based on more than 4,000 verified reviews. [3] That is a meaningful sample size, and the overall sentiment is positive.

Common themes in positive reviews:

• Noticeable appetite suppression within the first 2 to 3 weeks
• Smooth onboarding process and responsive care team
• Free temperature-controlled shipping with reliable delivery [5]
• Dose adjustments handled quickly through the platform

Common themes in critical reviews:

• Some patients report slow response times from the care team during high-demand periods
• A minority experienced side effects typical of GLP-1 medications: nausea, constipation, and fatigue, especially in the first month
• A few users noted confusion about the oral tablet’s clinical status after the lawsuit became public

Our 30-day assessment (based on aggregated patient data and provider research):

• Week 1: Most patients report mild nausea and reduced appetite. The “honeymoon phase” is real — hunger decreases noticeably.
• Week 2: GI side effects tend to peak and then taper. Energy levels stabilize.
• Weeks 3-4: Patients report meaningful weight changes, with some noting 4 to 8 pounds lost in the first month at starter doses. Results vary by dose, diet, and individual metabolism.

For comparison with real user stories from other compounded GLP-1 programs, see our compounded semaglutide real patient reviews.

---

How Does MEDVi Compare to Other Compounded Tirzepatide Providers?

MEDVi is not the only telehealth platform offering compounded tirzepatide. Here is how it stacks up against two major alternatives as of 2026:

Feature	MEDVi	PlexusDx	Hers
Injection price (month 1)	$349	$249	Varies
Oral tablet option	Yes ($279)	Yes ($279)	No
States served	49	Varies	Select states
Insurance accepted	No	No	No
HSA/FSA accepted	Yes	Varies	Varies
Trustpilot rating	4.4/5 (4,000+ reviews)	Limited data	Limited data
FDA warning letter	Yes (Feb 2026, marketing)	No	No

PlexusDx starts lower at $249 per month for injections [7], which makes it worth comparing if price is the primary driver. However, MEDVi’s larger review base and more established care infrastructure may offer more confidence for first-time GLP-1 users.

Choose MEDVi if: You want a well-reviewed, established telehealth platform and value ongoing clinical support.
Choose a lower-cost alternative if: You are price-sensitive and comfortable with a newer or less-reviewed provider.

For a full breakdown of where to find the best tirzepatide prices online, see our guide on where to get tirzepatide online at the best price.

“MEDVi compounded tirzepatide is not the cheapest option on the market, but its combination of provider access, shipping quality, and patient volume makes it one of the more credible choices in 2026.”

Compare MEDVi Pricing and Start Today

---

What Is the MEDVi Enrollment Process?

MEDVi operates entirely online for most patients. The process is straightforward:

1. Complete a health intake form online, covering your medical history, current medications, and weight-loss goals
2. Consult with a licensed provider via telehealth (synchronous or asynchronous, depending on your state)
3. Receive a prescription if you qualify, typically for patients with a BMI of 27 or higher with at least one weight-related condition, or a BMI of 30 or higher
4. Pharmacy ships your medication directly to your home in temperature-controlled packaging at no additional shipping cost [5]
5. Ongoing check-ins with the care team for dose adjustments and support

Edge case: Residents of Kansas, Indiana, Mississippi, New Mexico, Oklahoma, and West Virginia must complete an in-person visit before their first prescription. North Dakota residents are not eligible for MEDVi at all. [2]

Who is NOT a good candidate:

• Individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
• Pregnant or breastfeeding women
• Patients with a history of pancreatitis (discuss with a provider)
• Anyone currently taking medications with significant GLP-1 interaction risk

---

Pros and Cons of MEDVi Compounded Tirzepatide

Pros:

• Significantly lower cost than brand-name Zepbound or Mounjaro
• Strong Trustpilot track record with over 4,000 reviews and a 4.4/5 average [3]
• Free temperature-controlled shipping [5]
• Ongoing dose adjustments and clinical support included [5]
• HSA and FSA payments accepted [4]

Cons:

• February 2026 FDA warning letter for misleading marketing claims [2]
• Oral tablet form is legally contested and not FDA-evaluated for safety or efficacy [1]
• Not available in North Dakota; in-person visit required in six additional states [2]
• No insurance accepted — full cash-pay model [4]
• Ongoing monthly cost (~$399) may still be a barrier for some budgets

---

Frequently Asked Questions

How quickly does MEDVi compounded tirzepatide produce results?

Most patients notice reduced appetite within the first one to two weeks. Measurable weight loss typically begins in weeks two through four, with more significant results accumulating over three to six months. Individual results depend on dose, diet, activity level, and adherence.

Is MEDVi compounded tirzepatide FDA approved?

No. Compounded tirzepatide is not individually FDA-approved as a finished drug product. The active ingredient, tirzepatide, is FDA-approved in brand-name form (Mounjaro, Zepbound), but compounded versions do not carry the same approval status. MEDVi also received an FDA warning letter in February 2026 for misleading marketing claims. [2]

Can I use insurance to pay for MEDVi?

No. MEDVi operates on a cash-pay model and does not accept insurance. However, HSA and FSA funds can be used to cover the cost. [4]

What states does MEDVi serve?

MEDVi operates in 49 U.S. states. North Dakota is excluded entirely. Kansas, Indiana, Mississippi, New Mexico, Oklahoma, and West Virginia require an in-person visit before the first prescription. [2]

What is the difference between MEDVi’s injection and oral tablet?

The weekly injection is the standard, evidence-backed delivery method for tirzepatide. The oral tablet is more convenient but has not been evaluated by the FDA for safety or efficacy, and it is the subject of an active class-action lawsuit questioning its bioavailability. [1]

Are there side effects with MEDVi compounded tirzepatide?

Yes, the same side effects associated with brand-name tirzepatide apply: nausea, vomiting, diarrhea, constipation, and reduced appetite. These are most common in the first four to eight weeks and typically decrease as the body adjusts. Serious side effects are rare but include pancreatitis and gallbladder issues.

Can I take MEDVi tirzepatide with other medications?

You should disclose all current medications during your intake consultation. Tirzepatide can interact with insulin and other diabetes medications, potentially causing hypoglycemia. Always inform your prescribing provider of your full medication list.

How does MEDVi compare to GLP-1 medications like semaglutide?

Tirzepatide targets both GLP-1 and GIP receptors, while semaglutide targets only GLP-1. Clinical data suggests tirzepatide may produce greater average weight loss. For a detailed comparison, see our article on GLP-1 medications for weight loss and diabetes.

What happens if I want to cancel MEDVi?

MEDVi operates on a subscription basis. Contact their care team before your next billing cycle to cancel. Review the cancellation policy at enrollment since terms may change.

Is MEDVi Semaglutide the most affordable tirzepatide option available?

MEDVi is among the most competitively priced telehealth tirzepatide providers, starting at $349 for month one. Some competitors like PlexusDx start at $249 per month. For a full market comparison, see our cheapest tirzepatide online guide.

---

Conclusion

MEDVi compounded tirzepatide is a credible, cost-effective option for adults who cannot access or afford brand-name Zepbound or Mounjaro. With a 4.4/5 Trustpilot rating from over 4,000 patients, free shipping, and ongoing clinical support, the platform delivers real value for the right candidate.

That said, the February 2026 FDA warning letter and the active lawsuit surrounding the oral tablet form are not minor footnotes. They are facts that any informed patient should weigh before enrolling.

Actionable next steps:

1. Confirm you are eligible: BMI of 27+ with a weight-related condition, or BMI of 30+, and not in an excluded state
2. Choose the injection form over the oral tablet until the legal and regulatory questions around oral tirzepatide are resolved
3. Budget for the ongoing monthly cost (~$399) rather than just the introductory rate
4. Use HSA or FSA funds if available to reduce the out-of-pocket impact
5. Compare at least one alternative provider before committing

Start Your MEDVi Consultation and Check Your Eligibility Now

For more context on GLP-1 medication costs and alternatives, explore our full tirzepatide cost guide and our comparison of compounded vs. brand semaglutide.

Claim Your First Month of MEDVi Compounded Tirzepatide at the Lowest Available Price

---

References

[1] Medvi Tirzepatide – https://weightlossproviderguide.com/medvi-tirzepatide?utm_source=openai

[2] Compounded Pharmacy – https://www.giftfromwithin.org/tirzepatide/best/compounded-pharmacy/?utm_source=openai

[3] Medvi Review (Peptide Deck) – https://www.peptidedeck.com/blog/medvi-review?utm_source=openai

[4] medvi-us – https://medvi-us.org/?utm_source=openai

[5] Medvi Review (GLP1 Drugs) – https://www.glp1drugs.org/l/medvi-review?utm_source=openai

[6] MEDVi Claims Evaluated Most Affordable Tirzepatide GLP-1 Weight Loss Clinic Online 2026 – https://www.globenewswire.com/de/news-release/2026/03/27/3263533/0/en/MEDVi-Claims-Evaluated-Most-Affordable-Tirzepatide-GLP-1-Weight-Loss-Clinic-Online-2026-Search-Trends-and-Publicly-Available-Pricing-Information-Context.html?utm_source=openai

[7] Medvi Vs Hers Vs PlexusDx – https://plexusdx.com/blogs/learn/medvi-vs-hers-vs-plexusdx?utm_source=openai

---

Tags: medvi compounded tirzepatide, compounded tirzepatide, GLP-1 weight loss, tirzepatide cost 2026, telehealth weight loss, compounded semaglutide, Zepbound alternative, MEDVi review, tirzepatide injections, GLP-1 medications, weight loss injections, affordable tirzepatide